Research indicates a potential link between COVID-19 and an increased risk of new-onset dementia in adults over 60, with the risk being similar to that from other respiratory infections.
PharmaDrug’s Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – August 19, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on